S&P 500   3,307.27 (-0.44%)
DOW   29,021.63 (-0.56%)
QQQ   223.53 (-0.15%)
AAPL   317.33 (-0.12%)
FB   220.32 (-0.45%)
MSFT   165.95 (+0.15%)
GOOGL   1,481.77 (-0.16%)
AMZN   1,879.20 (-0.44%)
NVDA   250.05 (+0.00%)
BABA   218.25 (-1.85%)
MU   59.47 (+0.51%)
GE   11.73 (+3.17%)
TSLA   574.76 (+0.91%)
AMD   51.08 (-0.68%)
T   38.66 (-0.97%)
ACB   2.09 (+2.45%)
F   9.03 (-1.42%)
NFLX   336.07 (+3.09%)
DIS   141.73 (-1.58%)
GILD   63.21 (-0.35%)
S&P 500   3,307.27 (-0.44%)
DOW   29,021.63 (-0.56%)
QQQ   223.53 (-0.15%)
AAPL   317.33 (-0.12%)
FB   220.32 (-0.45%)
MSFT   165.95 (+0.15%)
GOOGL   1,481.77 (-0.16%)
AMZN   1,879.20 (-0.44%)
NVDA   250.05 (+0.00%)
BABA   218.25 (-1.85%)
MU   59.47 (+0.51%)
GE   11.73 (+3.17%)
TSLA   574.76 (+0.91%)
AMD   51.08 (-0.68%)
T   38.66 (-0.97%)
ACB   2.09 (+2.45%)
F   9.03 (-1.42%)
NFLX   336.07 (+3.09%)
DIS   141.73 (-1.58%)
GILD   63.21 (-0.35%)
S&P 500   3,307.27 (-0.44%)
DOW   29,021.63 (-0.56%)
QQQ   223.53 (-0.15%)
AAPL   317.33 (-0.12%)
FB   220.32 (-0.45%)
MSFT   165.95 (+0.15%)
GOOGL   1,481.77 (-0.16%)
AMZN   1,879.20 (-0.44%)
NVDA   250.05 (+0.00%)
BABA   218.25 (-1.85%)
MU   59.47 (+0.51%)
GE   11.73 (+3.17%)
TSLA   574.76 (+0.91%)
AMD   51.08 (-0.68%)
T   38.66 (-0.97%)
ACB   2.09 (+2.45%)
F   9.03 (-1.42%)
NFLX   336.07 (+3.09%)
DIS   141.73 (-1.58%)
GILD   63.21 (-0.35%)
S&P 500   3,307.27 (-0.44%)
DOW   29,021.63 (-0.56%)
QQQ   223.53 (-0.15%)
AAPL   317.33 (-0.12%)
FB   220.32 (-0.45%)
MSFT   165.95 (+0.15%)
GOOGL   1,481.77 (-0.16%)
AMZN   1,879.20 (-0.44%)
NVDA   250.05 (+0.00%)
BABA   218.25 (-1.85%)
MU   59.47 (+0.51%)
GE   11.73 (+3.17%)
TSLA   574.76 (+0.91%)
AMD   51.08 (-0.68%)
T   38.66 (-0.97%)
ACB   2.09 (+2.45%)
F   9.03 (-1.42%)
NFLX   336.07 (+3.09%)
DIS   141.73 (-1.58%)
GILD   63.21 (-0.35%)
Log in
(Ad)
And Reuters magazine calls this type of trading "the new baby boomer hobby." An anonymous trader -- living at the base of the Smoky Mountains -- just released a free report revealing a step-by-step system to generating an extra $5,000 per month in income thanks to this trading strategy. The report is free until Sunday.

OTCMKTS:ERBA - ERBA Diagnostics Stock Price, Forecast & News

$0.19
0.00 (0.00 %)
(As of 01/23/2020 11:15 AM ET)
Today's Range
$0.19
Now: $0.19
$0.19
50-Day Range
$0.10
MA: $0.13
$0.19
52-Week Range
$0.06
Now: $0.19
$0.34
Volume1,006 shs
Average Volume24,881 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta1.02
ERBA Diagnostics, Inc., through its subsidiaries, develops, manufactures, and markets diagnostic test kits or assays, and automated systems that are used to aid in the detection of disease markers primarily in the areas of autoimmune, infectious diseases, clinical chemistry, hematology, and diabetes testing. It manufactures scientific and laboratory instruments, such as Mago 4, Mago 4S, and Mago Plus systems, which perform tests in an automated mode; sells other diagnostic products manufactured by third parties in Italy; and develops, manufactures, and markets raw materials, such as antigens that are used in the production of diagnostic kits. The company also develops, manufactures, and markets autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers. In addition, the company provides instruments for blood cell counting and blood analysis; supplies reagents and other consumable materials; sells diabetic testing products, including the DS5 instrument, dispenser, and associated reagent kits, which measure long-term glucose control in diabetic patients; and offers equipment for use in the field of human and veterinary hematology. Further, it manufactures and sells liquid stable, diagnostics chemistry reagents used for in vitro diagnostics testing. The company markets its products through its sales force to hospitals, reference laboratories, clinical laboratories, and research laboratories, as well as to other commercial companies that manufacture diagnostic products in the United States; and through sales representatives and independent agents in Italy, as well as through independent distributors internationally. The company was founded in 1980 and is headquartered in Miami Lakes, Florida. ERBA Diagnostics, Inc. is a subsidiary of ERBA Diagnostics Mannheim GmbH.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ERBA
Previous SymbolNYSEMKT:ERB
CUSIPN/A
Phone305-324-2300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive ERBA News and Ratings via Email

Sign-up to receive the latest news and ratings for ERBA and its competitors with MarketBeat's FREE daily newsletter.


ERBA Diagnostics (OTCMKTS:ERBA) Frequently Asked Questions

What is ERBA Diagnostics' stock symbol?

ERBA Diagnostics trades on the OTCMKTS under the ticker symbol "ERBA."

Has ERBA Diagnostics been receiving favorable news coverage?

News articles about ERBA stock have been trending somewhat positive on Thursday, InfoTrie reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. ERBA Diagnostics earned a daily sentiment score of 1.6 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for ERBA Diagnostics.

Who are some of ERBA Diagnostics' key competitors?

What other stocks do shareholders of ERBA Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ERBA Diagnostics investors own include Ekf Diagnostics (EKF), Synergy Pharmaceuticals (SGYP), Attunity (ATTU), ContraFect (CFRX), Catalyst Pharmaceuticals (CPRX), ImmunoGen (IMGN), IQIYI (IQ), Myriad Genetics (MYGN), Nektar Therapeutics (NKTR) and OHR Pharmaceutical (OHRP).

Who are ERBA Diagnostics' key executives?

ERBA Diagnostics' management team includes the folowing people:
  • Mr. Suresh Vazirani, Exec. Chairman & MD (Age 69)
  • Mr. David Barka, Interim Chief Exec. Officer (Age 38)
  • Mr. Nate Wells, Chief Financial Officer
  • Dr. Chandra Krishnan, Sr. VP of Global Sales, Marketing and Bus. Devel.

How do I buy shares of ERBA Diagnostics?

Shares of ERBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is ERBA Diagnostics' stock price today?

One share of ERBA stock can currently be purchased for approximately $0.19.

What is ERBA Diagnostics' official website?

The official website for ERBA Diagnostics is http://www.erbadiagnostics.com/.

How can I contact ERBA Diagnostics?

ERBA Diagnostics' mailing address is 14100 Nw 57th Court, Miami Lakes FL, 33014. The company can be reached via phone at 305-324-2300 or via email at [email protected]


MarketBeat Community Rating for ERBA Diagnostics (OTCMKTS ERBA)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  70 (Vote Underperform)
Total Votes:  139
MarketBeat's community ratings are surveys of what our community members think about ERBA Diagnostics and other stocks. Vote "Outperform" if you believe ERBA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ERBA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel